Safety and Immunogenicity of Two Influenza Virus Subunit Vaccines, with or without MF59 Adjuvant, Administered to Human Immunodeficiency Virus Type 1-Seropositive and -Seronegative Adults

The objective of this study was to evaluate and compare both the safety and tolerability and the humoral and cell-mediated immune responses for two influenza virus subunit vaccines, one with MF59 adjuvant (Fluad) and one without an adjuvant (Agrippal), in healthy and in human immunodeficiency virus...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Durando, P., Fenoglio, D., Boschini, A., Ansaldi, F., Icardi, G., Sticchi, L., Renzoni, A., Fabbri, P., Ferrera, A., Parodi, A., Bruzzone, B., Gabutti, G., Podda, A., Del Giudice, G., Fragapane, E., Indiveri, F., Crovari, P., Gasparini, R.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology (ASM) 2008
Témata:
Vaccine Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2238067/
https://ncbi.nlm.nih.gov/pubmed/18003811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00316-07
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky